Search Results - "Chan, Noel"

Refine Results
  1. 1

    Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings by Chan, Noel C, Li, Karen, Hirsh, Jack

    “…This study describes changes in portable oximeter–measured peripheral oxygen saturation (Spo2 or O2sat) in older adults before, during, and after wearing a…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Direct oral anticoagulants: evidence and unresolved issues by Chan, Noel, Sobieraj-Teague, Magdalena, Eikelboom, John W

    Published in The Lancet (British edition) (28-11-2020)
    “…Currently licenced direct oral anticoagulants selectively target thrombin (eg, dabigatran) or coagulation factor Xa (eg, apixaban, betrixaban, edoxaban, and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Antithrombotic Agents: New Directions in Antithrombotic Therapy by Chan, Noel C, Weitz, Jeffrey I

    Published in Circulation research (01-02-2019)
    “…Recent advances in our understanding of the contribution of thrombin generation to arterial thrombosis and the role of platelets in venous thrombosis have…”
    Get full text
    Journal Article
  6. 6

    Thromboprophylaxis After Hip or Knee Arthroplasty by Chan, Noel C., Bhandari, Mohit

    “…In the 1960s, the modern era of joint arthroplasty was launched following the first successful implantation of a long-lasting hip endoprosthesis. More than…”
    Get full text
    Journal Article
  7. 7

    Novel antithrombotic strategies for treatment of venous thromboembolism by Weitz, Jeffrey I., Chan, Noel C.

    Published in Blood (30-01-2020)
    “…Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of vascular death after…”
    Get full text
    Journal Article
  8. 8

    Advances in Antithrombotic Therapy by Weitz, Jeffrey I, Chan, Noel C

    “…Thrombosis remains a major cause of morbidity and mortality. Consequently, advances in antithrombotic therapy are needed to reduce the disease burden. This…”
    Get full text
    Journal Article
  9. 9

    Glaucoma as Neurodegeneration in the Brain by Chan, Jane W, Chan, Noel C Y, Sadun, Alfredo A

    Published in Eye and brain (01-01-2021)
    “…Glaucoma, a group of diseases characterized by progressive optic nerve degeneration that results in irreversible blindness, can be considered a…”
    Get full text
    Journal Article
  10. 10

    Prevention of Venous Thromboembolism in 2020 and Beyond by Nicholson, Matthew, Chan, Noel, Bhagirath, Vinai, Ginsberg, Jeffrey

    Published in Journal of clinical medicine (01-08-2020)
    “…Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism…”
    Get full text
    Journal Article
  11. 11

    New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors by Chan, Noel C., Weitz, Jeffrey I.

    “…FXI (factor XI) and FXII (factor XII) have emerged as targets for new anticoagulants that have the potential to be both more efficacious and safer than the…”
    Get full text
    Journal Article
  12. 12

    Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials by Weitz, Jeffrey I, Chan, Noel C

    Published in Thrombosis and haemostasis (01-05-2019)
    “…Many patients with venous thromboembolism (VTE) are at risk of recurrence if anticoagulant therapy is stopped. Whereas 3 months of anticoagulation treatment is…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Laboratory measurement of the direct oral anticoagulants by Dale, Brian J., Chan, Noel C., Eikelboom, John W.

    Published in British journal of haematology (01-02-2016)
    “…Summary Direct oral anticoagulants (DOACs), including the direct thrombin inhibitor, dabigatran, and the direct factor Xa (FXa) inhibitors, rivaroxaban,…”
    Get full text
    Journal Article
  15. 15

    Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants by Chan, Noel C, Eikelboom, John W, Weitz, Jeffrey I

    Published in Circulation research (29-04-2016)
    “…The direct oral anticoagulants (DOACs) represent a major advance in oral anticoagulant therapy and have replaced the vitamin K antagonists as the preferred…”
    Get full text
    Journal Article
  16. 16

    Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis by Xu, Ke, Chan, Noel C, Ibrahim, Quazi, Kruger, Paul, Sinha, Smita, Bhagirath, Vinai, Ginsberg, Jeffrey, Bangdiwala, Shrikant, Guyatt, Gordon, Eikelboom, John, Hirsh, Jack

    Published in Thrombosis and haemostasis (01-04-2019)
    “…Systematic reviews reporting time trends in mortality following major orthopaedic surgery are few and have limitations. They reported on only a fraction (<…”
    Get more information
    Journal Article
  17. 17
  18. 18

    The use of optical coherence tomography in neuro-ophthalmology by Chan, Noel C.Y, Chan, Carmen K.M

    Published in Current opinion in ophthalmology (01-11-2017)
    “…PURPOSE OF REVIEWIn the last decade, with the advances of optical coherence tomography (OCT) technology, different imaging protocols and analysis algorithms…”
    Get full text
    Journal Article
  19. 19

    Clinical Studies with Anticoagulants that Have Changed Clinical Practice by Hirsh, Jack, de Vries, Tim A C, Eikelboom, John W, Bhagirath, Vinai, Chan, Noel C

    Published in Seminars in thrombosis and hemostasis (01-04-2023)
    “…Anticoagulant therapy is the cornerstone of treatment and prevention of arterial and venous thromboembolism. Taking a historical perspective, starting in the…”
    Get more information
    Journal Article
  20. 20

    In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 mo by Chan, Noel C., Weitz, Jeffrey I.

    Published in Annals of internal medicine (01-11-2021)
    “…Chan said that compared with nonpregnant women, the daily risk for VTE increases at least 5-fold during pregnancy and 20-fold in the 6 weeks after delivery…”
    Get full text
    Journal Article